Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

XIFIN Executives to Speak at Executive War College on Industry Disruptors Affecting US Healthcare and Diagnostics

Lâle White Keynote Addresses Rising Consumerism, Evolving Pharmacy Roles, and the Potential of Big Data

At the 2022 Executive War College Conference on Laboratory and Pathology Management in New Orleans this week, XIFIN’s executive chairman and CEO Lâle White will present a keynote: “Consumers, Retail Pharmacies, and Big Data: New Market Dynamics Poised to Reshape Who Orders and Pays for Clinical Lab Services and Genetic Tests.”

Latest Aithority Insights: SAP Announces Q1 2022 Results With Continued Cloud Momentum

“Consumers, Retail Pharmacies, and Big Data: New Market Dynamics Poised to Reshape Who Orders and Pays for Clinical Lab Services and Genetic Tests.”

The competitive landscape for laboratories and pathology practices is changing. Consumer and retail businesses are becoming the next healthcare companies. White will discuss the opportunity for diagnostic providers to embark on strategic ventures between laboratory, pharmacy and other specialized diagnostics to offer disease specific care, and an exceptional patient experience at lower cost. Later that day, White will delve further into these and other opportunities as she moderates a panel discussion with industry leaders from Truvian Sciences, Lighthouse Lab Services, and Michigan Health Information Network (MiHIN).

Browse The Complete News About Aithority: Planar and OptiTrack Present Broadest Set of Broadcast Technologies at NAB 2022

Continuing on the theme of consumer driven healthcare XIFIN executives will discuss the role of revenue cycle management capabilities in the patient experience and the impact of denials and appeals. The laboratory and diagnostic sectors have seen dramatic changes over the past few years including acceleration of AI in digital pathology, at-home testing becoming part of the mainstream, Revenue Cycle Management automation and healthcare regulations such as the No Surprises Act. The need for data and technology has never been stronger as providers seek to adapt to the ever-changing state of healthcare and meet the demands of consumers for affordable, convenient and accessible care.

Read More About Aithority News MulticoreWare Inc.’s VVC Consortium Gains Momentum

 [To share your insights with us, please write to]

Comments are closed.